2013-09-14 11:24:59 - Recently published research from MarketLine, "Biotechnology in Europe", is now available at Fast Market Research
Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2008-12, and forecast to 2017). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Europe biotechnology market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
* The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.
* The European biotechnology market had total revenues of $79.4bn in 2012, representing a compound annual growth rate (CAGR) of 11.5% between 2008 and 2012.
* Life sciences companies
are increasingly targeting emerging markets such as China, India, Brazil, and others to supplement sales in the mature markets of U.S. and Europe.
* The performance of the market is forecast to decelerate, with an anticipated CAGR of 8% for the five-year period 2012 - 2017, which is expected to drive the market to a value of $116.8bn by the end of 2017.
Full Report Details at
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Europe
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Europe
Leading company profiles reveal details of key biotechnology market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Europe biotechnology market with five year forecasts
Macroeconomic indicators provide insight into general trends within the Europe economy
Key Questions Answered
What was the size of the Europe biotechnology market by value in 2012?
What will be the size of the Europe biotechnology market in 2017?
What factors are affecting the strength of competition in the Europe biotechnology market?
How has the market performed over the last five years?
What are the main segments that make up Europe's biotechnology market?
Partial Table of Contents:
TABLE OF CONTENTS
Market value forecast
Market value forecast
Five Forces Analysis
Threat of substitutes
Degree of rivalry
Boehringer Ingelheim GmbH
Merck & Co., Inc.
F. Hoffmann-La Roche Ltd
Related MarketLine research
LIST OF TABLES
Table 1: Europe biotechnology market value: $ billion, 2008-12
Table 2: Europe biotechnology market category segmentation: $ billion, 2012
Table 3: Europe biotechnology market geography segmentation: $ billion, 2012
Table 4: Europe biotechnology market value forecast: $ billion, 2012-17
Table 5: Boehringer Ingelheim GmbH: key facts
Table 6: Boehringer Ingelheim GmbH: key financials ($)
Table 7: Boehringer Ingelheim GmbH: key financials (EUR)
Table 8: Boehringer Ingelheim GmbH: key financial ratios
Table 9: Merck & Co., Inc.: key facts
Table 10: Merck & Co., Inc.: key financials ($)
Table 11: Merck & Co., Inc.: key financial ratios
Table 12: Amgen, Inc.: key facts
Table 13: Amgen, Inc.: key financials ($)
Table 14: Amgen, Inc.: key financial ratios
Table 15: AstraZeneca PLC: key facts
Table 16: AstraZeneca PLC: key financials ($)
Table 17: AstraZeneca PLC: key financial ratios
Table 18: F. Hoffmann-La Roche Ltd: key facts
Table 19: F. Hoffmann-La Roche Ltd: key financials ($)
Table 20: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 21: F. Hoffmann-La Roche Ltd: key financial ratios
LIST OF FIGURES
Figure 1: Europe biotechnology market value: $ billion, 2008-12
Figure 2: Europe biotechnology market category segmentation: % share, by value, 2012
Figure 3: Europe biotechnology market geography segmentation: % share, by value, 2012
Figure 4: Europe biotechnology market value forecast: $ billion, 2012-17
Figure 5: Forces driving competition in the biotechnology market in Europe, 2012
Figure 6: Drivers of buyer power in the biotechnology market in Europe, 2012
Figure 7: Drivers of supplier power in the biotechnology market in Europe, 2012
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology market in Europe, 2012
Figure 9: Factors influencing the threat of substitutes in the biotechnology market in Europe, 2012
Figure 10: Drivers of degree of rivalry in the biotechnology market in Europe, 2012
Figure 11: Boehringer Ingelheim GmbH: revenues & profitability
Figure 12: Boehringer Ingelheim GmbH: assets & liabilities
Figure 13: Merck & Co., Inc.: revenues & profitability
Figure 14: Merck & Co., Inc.: assets & liabilities
Figure 15: Amgen, Inc.: revenues & profitability
Figure 16: Amgen, Inc.: assets & liabilities
Figure 17: AstraZeneca PLC: revenues & profitability
Figure 18: AstraZeneca PLC: assets & liabilities
Figure 19: F. Hoffmann-La Roche Ltd: revenues & profitability
Full Table of Contents is available at:
MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.